Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation

International Journal of Cardiology

Volumn 133, Issue 2, 2009, Pages 266-268

  Stefanadi, Elli ^a   Tousoulis, Dimitris ^a   Antoniades, Charalambos ^a   Katsi, Vasiliki ^a   Bosinakou, Erini ^a   Vavuranakis, Emmanuel ^a   Triantafyllou, Georgia ^a   Marinou, Kyriakoula ^a   Tsioufis, Costas ^a   Papageorgiou, Nikolaos ^a   Latsios, George ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cytokines; Endothelium; Inflammation; ST elevated myocardial infarction; Statins

Indexed keywords

ATORVASTATIN; CHOLESTEROL; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM INJURY; FEMALE; HUMAN; KINETICS; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; TREATMENT DURATION; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PYRROLES; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR CELL ADHESION MOLECULE-1; VON WILLEBRAND FACTOR;

EID: 62049083636     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.11.025     Document Type: Article

References (5)

1. Tousoulis D., Antoniades C., Koumallos N., and Stefanadis C. Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev 17 (2006) 225-233
2. Ray K.K., Cannon C.P., and Ganz P. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?. Am J Cardiol 98 (2006) 18P-25P
3. Tousoulis D., Antoniades C., Katsi V., et al. The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level. Int J Cardiol 109 (2006) 48-52
4. Lee K.W., Blann A.D., and Lip G.Y. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes. Int J Cardiol 111 (2006) 302-308
5. Endres M. Statins: potential new indications in inflammatory conditions. Atheroscler Suppl 7 (2006) 31-35